SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-058152
Filing Date
2023-12-18
Accepted
2023-12-18 16:11:25
Documents
14
Period of Report
2023-12-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20016866_8k.htm   iXBRL 8-K 25646
2 EXHIBIT 99.1 ef20016866_ex99-1.htm EX-99.1 17087
6 image0.jpg GRAPHIC 53159
  Complete submission text file 0001140361-23-058152.txt   256573

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ions-20231218.xsd EX-101.SCH 3875
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20231218_lab.xml EX-101.LAB 22547
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20231218_pre.xml EX-101.PRE 16051
8 EXTRACTED XBRL INSTANCE DOCUMENT ef20016866_8k_htm.xml XML 4056
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 231493835
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)